Michael J. LaBarre - 10 Feb 2023 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Role
SVP, CHIEF TECHNICAL OFFICER
Signature
/s/ James R. Oehler, Attorney-in-Fact
Issuer symbol
HALO
Transactions as of
10 Feb 2023
Net transactions value
-$277,670
Form type
4
Filing time
14 Feb 2023, 16:24:29 UTC
Previous filing
18 Jan 2023
Next filing
17 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HALO Common Stock Options Exercise $0 +8,133 +5.7% $0.000000 151,270 10 Feb 2023 Direct
transaction HALO Common Stock Tax liability $144,363 -2,951 -2% $48.92 148,319 10 Feb 2023 Direct F1
transaction HALO Common Stock Options Exercise $0 +7,883 +5.3% $0.000000 156,202 12 Feb 2023 Direct
transaction HALO Common Stock Tax liability $133,307 -2,725 -1.7% $48.92 153,477 12 Feb 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HALO Restricted Stock Units Options Exercise $0 -8,133 -50% $0.000000 8,133 10 Feb 2023 Common Stock 8,133 $0.000000 Direct F3
transaction HALO Restricted Stock Unit Options Exercise $0 -7,883 -100% $0.000000* 0 12 Feb 2023 Common Stock 7,883 $0.000000 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported disposition of 2,951 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations.
F2 The reported disposition of 2,725 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations.
F3 This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.